this The Tandem Diabetes Care t:slim X2 insulin pump is appropriate with glucose monitoring specialist Dexcom’s G7 and G6 steady glucose monitoring (CGM) programs and has been authorized on the market by Well being Canada, the Canadian authorities division answerable for nationwide well being coverage.
The t:slim holds as much as 300 items of insulin, contains a shade contact display screen, a chargeable battery powered by way of a micro-USB port, the power to create six customized profile settings, and integration with a number of CGM sensing Integration capabilities.
The pump’s Management-IQ know-how helps with diabetes administration through the use of sensor values ​​to foretell blood glucose ranges half-hour prematurely and mechanically alter insulin when wanted.
When insulin pumps develop into typically obtainable to clients within the fall, Tandem will e-mail them directions to assist them select between the G7 or G6 platforms. The corporate will then ship the machine with the chosen software program pre-installed.
The G7’s built-in sensor and transmitter are 60% smaller than the Dexcom G6, and the system can be waterproof.
Customers additionally take pleasure in a 30-minute sensor warm-up time and a 12-hour grace interval for sensor substitute, and the G7 additionally gives improved connectivity with a number of digital well being apps.
Each programs permit customers to take readings each 5 minutes in the course of the day and night time, in addition to predictive “emergency low-speed alerts.”
These alerts will activate as much as 20 minutes earlier than vital lows fall under 3.1 mmol/L, and emergency low alerts will activate for quick notification when blood sugar drops under 3.1 mmol/L.
bigger pattern
In June, Dexcom introduced Expands diabetes administration capabilities by offering a direct Bluetooth connection between the G7 steady glucose monitoring system and Apple Watch.
This function, which permits prompt blood glucose readings with out an iPhone, is presently obtainable in the USA, the UK, and Eire, with extra markets anticipated to comply with.
Earlier this 12 months, the corporate’s OTC Stelo Glucose Biosensor is a wearable biosensor with a battery lifetime of as much as two weeks and is FDA authorized. This machine offers perception into the consumer’s blood sugar well being.
One other participant within the subject is biosensor know-how startup Allez Well being, based by former Dexcom workers. alez Developed a CGM platform and obtained $60 million in Sequence A+ financing in Could.
